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Strengths and limitations of this study
 ► This is the first systematic review to assimilate 
and compare the findings of existing literature on 
the health outcome and treatment priorities of 
both clinicians treating and patients living with 
multimorbidity.
 ► We have included papers using both qualitative and 
quantitative methodologies and have been able to 
explore patterns and relationships in the findings, 
thus creating a comprehensive and well- rounded 
systematic review.
 ► Our findings facilitate clinicians in understanding 
both how and why the health outcome and treat-
ment priorities of their patients with multimorbidity 
might differ from their own priorities.
 ► Meta- analysis of the quantitative studies was un-
feasible as there was a large variation in the tools 
used to ascertain priorities, and we have attempted 
to mitigate this by using a well- described and trans-
parent method of narrative synthesis.
 ► A number of our included quantitative studies did 
not use prevalidated tools to ascertain priorities, 
leading to a risk of measurement bias.
AbStrACt
Objectives To identify studies that have investigated 
the health outcome and treatment priorities of patients 
with multimorbidity, clinicians or both, in order to assess 
whether the priorities of the two groups are in alignment, 
or whether a disparity exists between the priorities of 
patients with multimorbidity and clinicians.
Design Systematic review.
Data sources MEDLINE, EMBASE, CINHAL and Cochrane 
databases from inception to May 2019 using a predefined 
search strategy, as well as reference lists containing any 
relevant articles, as per Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses and Cochrane 
guidelines.
Eligibility criteria We included studies reporting health 
outcome and treatment priorities of adult patients with 
multimorbidity, defined as suffering from two or more 
chronic conditions, or of clinicians in the context of 
multimorbidity or both. There was no restriction by study 
design, and studies using quantitative and/or qualitative 
methodologies were included.
Data synthesis We used a narrative synthesis approach 
to synthesise the quantitative findings, and a meta- 
ethnography approach to synthesise the qualitative 
findings.
results Our search identified 24 studies for inclusion, 
which comprised 12 quantitative studies, 10 qualitative 
studies and 2 mixed- methods studies. Twelve studies 
reported the priorities of both patients and clinicians, 10 
studies reported the priorities of patients and 2 studies 
reported the priorities of clinicians alone. Our findings 
have shown a mostly low level of agreement between the 
priorities of patients with multimorbidity and clinicians. 
We found that prioritisation by patients was mainly driven 
by their illness experiences, while clinicians focused on 
longer- term risks. Preserving functional ability emerged as 
a key priority for patients from across our quantitative and 
qualitative analyses.
Conclusion Recognising that there may be a disparity in 
prioritisation and understanding the reasons for why this 
might occur, can facilitate clinicians in accurately eliciting 
the priorities that are most important to their patients and 
delivering patient- centred care.
PrOSPErO registration number CRD42018076076.
IntrODuCtIOn
Multimorbidity, defined as the coexistence of 
two or more long- term conditions,1 is a global 
problem,2 which has become the norm across 
high- income countries2–5 and becoming 
increasingly prevalent in middle- income and 
low- income countries.2 6 7 Guidelines for the 
management of chronic diseases are often 
single disease orientated, and can lead to 
confusion and complications when applied 
to patients with multimorbidity.8 Patients 
with multimorbidity have an increased risk of 
adverse drug- related events as a result of high 
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Figure 1 Flow diagram to illustrate process from literature 
searching to selection of studies for inclusion.28
levels of polypharmacy and receiving uncoordinated care 
from multiple healthcare providers.9 These patients have 
a poorer health- related quality of life,10 poorer functional 
status11 and greater psychological distress.12 As a result, 
understanding and finding better strategies to facilitate 
the management of patients with multimorbidity has 
been identified as a priority for health research.13
Key to the effective management of multimorbidity is 
using patient- centred care and shared decision making 
to set management goals that are acceptable to both the 
patient and the clinician.14 Incorporating the priorities of 
patients in relation to treatments and health outcomes is 
integral to this process.15–17 However, previous research 
has shown that while doctors recognise the importance of 
eliciting and incorporating the priorities of their patients 
with multimorbidity, they do not always engage with this 
process in real- world settings, and find eliciting patients’ 
priorities to be difficult.18 19 Previous research, completed 
in a single disease context, has shown that the treatment 
and health outcome priorities of patients and clinicians 
can differ,20–22 and some studies have highlighted a gap 
between what doctors’ perceive to be the priorities of their 
patients, and the actual priorities of their patients.23–25
This systematic review aims to identify studies that have 
investigated the health outcome and treatment priori-
ties of patients with multimorbidity, clinicians or both, in 
order to assess whether the priorities of the two groups are 
in alignment, or whether there is a disparity between the 
priorities of patients with multimorbidity and clinicians.
MEthODS
Search strategy
A comprehensive search strategy (online supplemen-
tary appendix 1),was developed using guidance for the 
best practice26 and input from academic librarians at the 
University of Leicester. The search strategy was used to 
search MEDLINE, EMBASE, CINHAL and COCHRANE 
databases from inception to May 2019, as well as searching 
reference lists for any relevant articles based on Preferred 
Reporting Items for Systematic Reviews and Meta- 
Analyses and Cochrane guidelines.26–28 We undertook a 
scoping search using google scholar using our key terms 
(Patient*; Priorit*; Clinician, Physician, Doctor, General- 
practitioner, Family- practitioner; Multimorbidit*; Multi 
morbid*) to identify relevant grey literature. Citations 
were stored using Refworks. We have presented our 
process of article selection in figure 1.
We included studies reporting the health outcome and 
treatment priorities of adult patients with multimorbidity1 
and/or clinicians, in relation to patients with multimor-
bidity. Studies which did not specify the definition of 
multimorbidity as ‘two or more chronic conditions’1 in 
their inclusion criteria, but had a sample patients repre-
sentative of being diagnosed with multimorbidity (ie, 
with a minimum of two chronic conditions) were also 
included. There was no restriction by study design, and 
we included studies using quantitative and/or qualitative 
methodologies. We excluded studies not published in 
English language, studies with participants aged under 18 
years and studies focusing on a single disease area.
Patient and public involvement
Patient and public involvement was not applicable in the 
design, conduct or reporting of this review.
Study selection
The titles and abstracts of all articles identified by the 
literature search were assessed independently and in 
duplicate by two reviewers (HS and RF). Studies that did 
not meet inclusion criteria were discarded. Full text of 
selected articles was retrieved and assessed to determine 
if they met the inclusion criteria, and those studies which 
met the inclusion criteria were included in the review. 
Any discrepancies regarding eligibility of an article were 
discussed, and consensus reached with MS and SS.
Methodological quality assessment and data extraction
Data were extracted using standardised data extraction 
forms by a single reviewer (HS), and these were checked 
independently for accuracy by a second reviewer (SS). 
The reported health outcome and treatment priorities 
of study participants were the key outcomes that were 
extracted.
Quality assessment was carried out in parallel with the 
data extraction process. For the quantitative studies, due 
to the heterogeneity of study design, we used the Appraisal 
tool for Cross- sectional Studies (AXIS tool) for assessment 
for the cross- sectional studies,29 the Newcastle- Ottawa 
scale for assessment of the longitudinal observational and 
cohort studies,30 and the Cochrane collaboration's risk of 
bias tool for assessment of randomised controlled trials.31 
For the qualitative studies, we used the Critical Appraisal 
by copyright.
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Skills Programme (CASP) checklist for appraisal of qual-
itative research.32 For the two mixed- methods studies, we 
used the AXIS tool29 to assess the quantitative aspects of 
the study (both cross- sectional in study design), and the 
CASP checklist for qualitative research,32 to assess the 
qualitative aspects of these studies.
Data synthesis
We decided a priori not to carry out a meta- analysis due to 
the heterogeneity of the quantitative studies. Therefore, 
we have taken a narrative synthesis approach, described 
by Popay et al33 to synthesise our quantitative findings. 
Our approach consists of three key steps:
1. Development of a preliminary synthesis in which study 
characteristics and descriptions are collated and find-
ings presented in a summary table.
2. Exploring relationships in the data between study char-
acteristics and their findings, as well as between the re-
ported findings across different studies with explana-
tions considered where relationships were identified.
3. Assessing the robustness of the synthesis using quality 
assessment tools to guide conclusions and identify di-
rections for clinical practice.
Qualitative studies were synthesised using a meta- 
ethnography approach,34 35 which consisted of careful 
reading of the papers, extracting information regarding 
the context of the study and findings. Key concepts 
arising from each paper were also identified, with pres-
ervation of the terminology used by the authors where 
possible to ensure accurate representation of the find-
ings of the original studies. The key concepts across the 
papers were then translated using a table summarising 
the studies, their findings in relation to the key concepts 
and the second order interpretations of the authors, 
which enabled the exploration of any relationships and 
differences. The translations were then synthesised using 
a table containing the first order and second order inter-
pretations for the key concepts across the studies, which 
then led to the development of further, third order inter-
pretations by reviewers.34 35
From the results of our narrative synthesis of the quan-
titative studies and meta- ethnography of the qualita-
tive studies, we considered how the findings of the two 
syntheses complement one another, particularly where 
our qualitative findings may provide possible explana-
tions for our quantitative findings. The outcome of this 
process is described in the discussion section.
rESultS
Overall study characteristics
Our search resulted in the identification of 24 studies for 
inclusion, which comprised 12 quantitative studies, 10 
qualitative studies and two mixed- methods studies. The 
characteristics of all of the included studies are described 
in table 1. The included studies had all been conducted 
in high- income developed countries, including 
Canada,36 37 USA,38–44 Netherlands,45 46 Australia,47 48 
UK,49–51 Germany52–55 and Switzerland.56–58 Sample sizes 
ranged from 15 to 1169 patients and 5 to 92 clinicians in 
the quantitative studies, and 15 to 146 patients and 4 to 19 
clinicians in the qualitative studies.
Summary of quality assessment
The outcome of quality assessment based on each of the 
aforementioned tools is summarised in online supple-
mentary appendix 2. The majority of the quantitative 
studies were cross- sectional in design,36 39 40 45–47 53 54 56–58 
including the quantitative elements of the two mixed- 
methods studies. The other studies included one cohort 
study44 and one randomised controlled trial.52 The cross- 
sectional studies were of moderate quality, with a number 
of studies having small sample sizes.40 45 46 54 The sample 
sizes of clinicians in most of the cross- sectional studies 
were particularly small, ranging from of 9 to 157 clini-
cians,45 46 54 57 which impacts on the generalisability and 
application of their findings. We noted that a number of 
the studies did not use prevalidated questions and tools to 
ascertain priorities,36 54 56–58 leading to a degree of subjec-
tivity in the way in which priorities were ascertained, and 
the risk of measurement bias which again impacts on the 
generalisability of their findings.
The majority of the qualitative studies, including the 
qualitative aspects of the two mixed- methods studies, 
used interviews for data collection (n=8). Two studies 
used focus groups,41 55 one study used a combination of 
focus groups and interviews49 and one study used the 
nominal group technique.48 The qualitative studies were 
of good quality, with appropriate use of qualitative meth-
odology and transparent descriptions of the data analysis 
processes. Three studies only gave a limited description of 
their analytic process,47–49 with two of these studies47 48 and 
one mixed- methods study,45 not presenting any quotes.
QuAntItAtIvE SynthESIS
Within our quantitative synthesis, we found that the 
studies focused either on the overall state of the patients’ 
health, the problems posed by different chronic disease 
groups or the patients’ treatment regimens. Some of 
the quantitative studies elicited patient and/or clinician 
priorities as part of an intervention.46 52 Therefore, in 
order to reduce the risk of bias from the interventions, 
we included only the preintervention results from these 
studies.
health outcome priorities
Four studies reported patient priorities of overall 
health outcomes using a ‘health outcome prioritisation 
tool’,39 40 45 which is a visual analogue scale requiring 
the following health outcomes to be given a score out of 
100: ‘maintaining independence’; ‘staying alive’; ‘pain 
relief’; ‘symptom relief’. Maintaining independence 
was the outcome that had the highest importance after 
a pooling of the most important rankings from the four 
studies, followed by ‘staying alive’ (table 2). For clinicians’ 
by copyright.
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review in older 
patients with 
multimorbidity: 
















Maintaining independence 270 (75.6) 34 (42.0) 7 (36.8) 19 (35.8) 330 (64.7)
Staying alive 40 (11.2) 22 (27.2) 6 (31.6) 18 (34.0) 86 (16.9)
Pain relief 26 (7.3) 17 (21.0) 1 (5.3) 6 (11.3) 50 (9.8)
Symptom relief 21 (5.9) 8 (9.8) 5 (26.3) 10 (18.9) 44 (8.6)
Total no of participants 357 81 19* 53 510
*Although there were 59 patients included in this study46 priorities were only reported for 19 patients.
priorities, one study reported that 98% of a sample of 157 
general practitioners (GPs) identified the ‘quality of life 
for the patient’, and 96% identified the ‘life expectancy 
of the patient’, as the most important factors in influ-
encing their clinical decision making to deprescribe for 
elderly, patients with multimorbidity.57
Priorities based on health problems
Three studies reported patient and GPs’ priorities based 
on various health problems, following a geriatric assess-
ment.52–54 These problems were then categorised into 
domains, and the importance rankings for each of the 
domains were presented. Problems in the domains of 
‘social’ ‘mood’ and ‘function’ recurrently featured in the 
top four of the most highly ranked priorities by patients 
across all three studies. In terms of the importance rank-
ings by clinicians, problems in the domains of ‘mood’ 
and ‘function’ also featured in the top four importance 
rankings across all three studies, while ‘social’ prob-
lems were rated highly in one study53 and problems in 
the domain of ‘medication’ were ranked highly in the 
other two studies.52 54 Interestingly, the authors in one 
study53 found that patients feeling ‘emotionally affected’ 
was the strongest predictor for a problem being rated as 
important (OR 11.1, 95% CI 6.73 to 18.33), whereas ‘poor 
prognosis’ was the strongest predictor for clinicians (OR 
6.39, 95% CI 4.61 to 8.87)
Condition-focused priorities
Two studies reported patient priorities in relation to 
specific conditions or groups of conditions,44 58 in the 
context of multimorbidity. Zulman et al reported that 
‘diabetes/glycaemic control’ was most frequently ranked 
as ‘most important’, with ‘hypertension’ coming second.44 
However, the sample of patients included in this study 
were all diabetic, hypertensive patients. Déruaz- Luyet 
et al found that musculoskeletal conditions, including 
back pain, were most frequently reported to be the 
most important conditions for their patients, however, 
endocrine/metabolic conditions (including obesity) 
were second and cardiovascular conditions were third.58
Three studies reported condition- focused priorities of 
clinicians in the context of multimorbidity. Herzig et al 
reported the priorities of GPs alone,56 and found that 
‘multiple sclerosis’, ‘mental retardation’ and ‘bronchus 
lung neoplasm’ were all highly prioritised by their partici-
pants. Zulman et al reported the priorities of ‘primary care 
providers’ who consisted of physicians, physician assis-
tants or nurse practitioners,44 and found that diabetes was 
the top priority for primary care providers, with hyperten-
sion coming second, in alignment with their previously 
described patient priorities.44 Moore et al examined the 
priorities of different types of clinicians, including family 
physicians, geriatricians and nurse practitioners,36 and as 
with Zulman et al, found that diabetes was the top priority 
for family physicians and also nurse practitioners, whereas 
dementia was the top priority for geriatricians.44 In addi-
tion, heart failure, atrial fibrillation and hypertension 
formed three of the top five conditions considered to be 
most important by the family practitioners in the study.36
treatment priorities
As part of a study to examine the influence of the risks 
and benefits of medications on treatment preferences 
of patients, Caughey et al also examined the priorities 
of patients in the face of ‘competing outcomes’.47 They 
found that 80% of participants would not be willing to 
take medication to reduce ‘joint pain’, if the medication 
increased their risk of a myocardial infarction by 10%. 
However, this was deduced from a sample of only 15 
patients.47
Agreement between patients and clinicians
Five of the included studies investigated the level of 
agreement in priority rankings between patients and 
their clinicians.44 52–54 58 Three studies reported a low level 
of agreement between patient and clinicians’ priority 
rankings.52–54 Two of these studies used a Cohen’s kappa 
by copyright.
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Table 3 Examples from included studies for key concepts relating to mechanisms of prioritisation





‘My final issue is diverticulitis. In many ways that is the thing that makes the most 
impact on my life because of the unreliability of it. You make plans to do something to 
go somewhere and at the last minute you don’t dare leave the house because you don’t 
leave the loo. In itself it’s not an important medical issue. It’s the social problem more 
than anything else.’ Lindsay et al49
Quality of life versus 
length of life
‘If you don't feel good, you can't take care of yourself and you have to depend on 
somebody else, what's the good of living another 10 years?’ Fried et al41
Facilitating clinicians’ 
decision making
‘In future, I'll be happier to be more decisive in keeping an eye on what we do and do not 
do as regards this patient.’ Van Summeren et al45
calculation to estimate the degree of agreement between 
the importance ratings of patients and clinicians, and 
the values of which were 0.18 and 0.11, respectively, indi-
cating ‘slight agreement’ after allowing for chance.53 54 
One study used a weighted kappa calculation to measure 
the degree of agreement, which, at a preintervention 
point in this study, was low at 6%.52
Two studies reported that there was a ‘high’ level of 
agreement.44 58 Déruaz- Luyet et al found that in the case of 
54.9% (n=314) of their patients, the condition that their 
GP had considered to be either the first or second most 
important, was in the same disease group as the condition 
that the patient considered to be most important.58
Zulman et al reported that 60% of ‘patient–provider 
pairs’ had a ‘high concordance’, meaning that the same 
three conditions had been rated as top three priorities 
by both parties, or that two of the same conditions had 
been rated in the top three priorities by both parties.44 
In this case, given that the samples of patients were all 
diabetic and hypertensive could have led to a narrowing 
of the range of chronic diseases across the sample, which 
in turn could have led to an increased likelihood of agree-
ment. However, the participant characteristics reported 
by the authors state that the patients had a mean of eight 
health conditions (SD 3.00), suggesting that the patients 
did not have a narrow range of chronic diseases. Further-
more, the questions posed to patients and providers 
were phrased differently, in that providers were asked to 
choose the top three most important medical concerns 
‘that are likely to affect health outcomes for this patient’, 
whereas patients were asked to choose their top three 
most important health concerns. The authors acknowl-
edge this in their paper, and justify this difference as 
being due to their aim of exploring the concordance in 
priorities about the ‘most important problems facing the 
patient’, rather which problems ‘providers thought the 
patient would have prioritised’, which, they argue, is a 
different concept to their aim.44
QuAlItAtIvE SynthESIS
While our quantitative synthesis allowed us to investi-
gate which health outcomes, diseases or treatments were 
important to patients with multimorbidity and their clini-
cians, our qualitative analysis enabled us to explore how 
prioritisation occurs. Below, we describe the key findings 
from our qualitative analysis.
Mechanisms of prioritisation
In the qualitative studies that approached prioritisa-
tion from a disease- specific perspective, patients were 
able to identify an illness as their main priority.49 50 For 
many patients, prioritisation appeared to be driven by 
their experience of the illness, which formed part of its 
‘meaning as consequence50’ as phrased by Cheraghi- 
Sohi et al. The ‘consequences’ of an illness consisted of 
the impact that the illness was having on the patients’ 
everyday lives, which included functional limitation and 
the symptomatic burden of the illness, including its 
‘unpredictability’ (table 3).49 For others, prioritisation 
appeared to be driven by their perception of the risk now 
and in the future with respect to functional deterioration 
and mortality.
In other studies, patients framed their priorities 
between quality of life versus length of life (table 3).42 
Patients in the study by Naik et al who were adults with 
multimorbidity and suffering from cancer, prioritised 
‘quality of life’ more highly than ‘length of life’.42 This was 
also reflected in the findings of Fried et al, who found that 
when considering medication with competing outcomes 
in terms of extending life compared with quality of life, 
participants appeared to prioritise preserving quality of 
life.41
van Summeren et al found that prioritisation was ‘diffi-
cult’ when there was no ‘specific need’ for a treatment 
decision to be made.45 This concept of a difference in 
prioritisation based on hypothetical, or experiential 
levels, was also shared in the findings of Elliott et al43 and 
Fried et al.41
Where clinicians’ perspectives were explored along-
side patients, clinicians reported that exploring patients’ 
priorities was ‘extremely important’ when managing 
‘competing interests’47 and beneficial in providing 
patient- centred care.45 Some clinicians in the mixed- 
methods study carried out by van Summeren et al reported 
that exploring their patients’ priorities allowed them to 
have a ‘deeper understanding‘ of the patient, helped with 
making patient- centred treatment decisions and advance 
care planning (table 3).45 However, other clinicians in 
the same study found exploring patient priorities to be 
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Table 4 Examples from included studies for key concepts relating to factors influencing prioritisation
Concept Examples from included studies
Factors influencing 
prioritisation
Functional ability ‘I mean, because I have to be mobile, I am living on my own, no one is going to take 
care of me, I have got to look after myself…’ Cheraghi- Sohi et al50
Mortality ‘Well I really do worry the most about the high blood pressure. ’Cause see you know 
you got arthritis and you can tell when it’s coming on. But you can’t hardly tell about 
high blood pressure. It can just hit you like that [snaps fingers] ….’ Lindsay et al49




‘… I talk [to her] for a quarter of an hour about this and that every time after which 
she replies, ‘but my vertigo,’ and I answer every time, well, unfortunately there 
is nothing I can do about it, we have already tried and done everything. But it 
is probably the first diagnosis she will mention: ‘What are you suffering from?’. 
‘Vertigo’. For me, this would be somewhere all the way at the bottom.’ Hansen et al55
Treatment burden ‘It’s the knee that’s the most concerning because everything else is controlled by 
tablets. The knee is a problem because if I have one little slip I’m in plaster again for 
6 weeks.’ Lindsay et al49
difficult due its ‘novelty’ and the fact that it represented a 
change to their usual consultations.45
Factors influencing prioritisation
Our analysis revealed that there were a number of factors 
that appeared to influence how both patients and clini-
cians arrived at their priorities, and which priorities they 
chose.
Functional ability
Preserving functional ability as a priority for patients was 
a dominant concept across the majority of the qualitative 
studies.37 38 41 42 47 49 51 Preserving independence emerged 
as the most significant reason for prioritising functional 
ability for patients, and maintaining the ability to engage 
in activities of daily living, mobility, maintaining cognitive 
ability and wanting to avoid being a ‘burden’ or lacking 
social support to help them cope with functional deterio-
ration (table 4).38 49 50
Conditions, which caused limitation to patients’ ability 
to self- manage their health conditions, led to a ‘tension’ 
between the patients’ expectations of themselves and what 
they were physically able to do.51 Lifestyle management, 
particularly reduced ability to exercise and the adverse 
impact of this on weight, was cited as part of patients’ 
ability to self- manage.49
Maintaining patients’ functional ability was reported 
as a priority by some clinicians.37 47 Clinicians considered 
the wider implications of the patients’ functional deterio-
ration, particularly cognitive deterioration, and spoke of 
wanting to reduce the risk of ‘burnout’ for the patients’ 
family members/caregivers.37
Mortality
Reducing the risk of mortality emerged as a recurrent 
priority for clinicians.47 55 Caughey et al found that clini-
cians prioritised mortality in younger (less than 65 years) 
patients with multimorbidity rather than older patients 
with multimorbidity, as they felt they could be more 
‘aggressive’ in their treatment.47 Reducing the risk of 
mortality also emerged as a priority for patients across a 
number of studies.37 38 42 43 50 51 Some patients found the 
asymptomatic nature of hypertension to be concerning; 
hence, the consequences of hypertension could be unpre-
dictable, compared with some other chronic illnesses 
where symptoms can give warning of onset and severity 
(table 4).38 43
Symptom control
The symptomatic burden of a condition contributed to its 
‘meaning as consequence’ for patients.50 Symptoms were 
cited as being a cause of functional limitation,38 49 and in 
some cases their ‘unpredictability’ could cause significant 
disruption to patients’ daily lives.49 Symptom control was 
reported to be a priority by some clinicians.37 47 However, 
clinicians in one study considered symptom control to 
be less important, particularly when there was no risk of 
mortality.55 In these cases, clinicians seemed to be aware 
that patients may still be prioritising symptom control 
highly, even if the clinicians did not (table 4).
Treatment burden
Factors related to the treatment burden of an illness 
appeared to adversely impact prioritisation for patients, 
leading to de prioritisation of certain medications and 
treatments.38 41 43 48 Elliot et al reported that cost and 
distressing side effects were factors which led patients 
to stop taking a medication.43 Similarly, Fried et al found 
that patients reported unpleasant side effects to be a 
‘competing outcome’, which negatively influenced their 
decision regarding continuing a medication.41 However, 
difficulty with achieving control over the management 
of an illness, as well as requirement for high levels of 
engagement with self- management, emerged as factors 
that contributed to the prioritisation of an illness by some 
patients (table 4).49
DISCuSSIOn
Prioritisation as a concept is broad, context dependent 
and difficult to confine into a single definitive definition. 
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As a result, determining what can be interpreted as a 
health outcome or treatment priority as part of our 
study selection in this review was inherently difficult. 
We excluded some studies that investigated the prefer-
ences of patients with multimorbidity or clinicians, in 
contexts that we judged to be different to the aim of this 
review. These included patient preferences for healthcare 
delivery,59 60 levels of engagement with self- management 
practices61 62 and clinicians’ experiences of the manage-
ment of patients with multimorbidity.18 63 64 While these 
studies represent very important areas of research, they 
were not within the scope of our aim in this review, that 
is, identifying studies that report the health outcome and 
treatment priorities of patients with multimorbidity or 
those of clinicians in relation to patients with multimor-
bidity. A discussion from our synthesis of findings of the 
included studies in this review is presented below.
health outcome and treatment priorities
From our findings, patients’ prioritisation appeared to be 
driven by weighing up the empirical compared with the 
hypothetical impact of a disease, whereby the empirical 
impact of a disease, which included its impact on func-
tion, symptomatic and treatment burden, was the most 
dominant driver of prioritisation. This is consistent with 
the findings of previous literature showing patients with 
rheumatoid arthritis who had reported experiencing 
higher levels of pain, were more likely to report pain as 
a priority.65
Among empirical factors, preserving functionality 
emerged as most highly prioritised by patients among 
the quantitative studies that took a health outcome 
approach,39 40 46 while ‘function’ was a domain that was 
prioritised highly by both patients and clinicians in the 
studies where prioritisation of various health problems 
were investigated.52–54 From our qualitative findings, 
functional ability formed a key part of the preservation 
of various aspects of the patients’ independence and 
their quality of life, as well as their ability to self- manage. 
Existing evidence shows that the prevalence of multimor-
bidity is highest in those aged over 65 years,66 and the 
population for the majority of the included studies were 
older adults with multimorbidity. This could provide an 
explanation for why preserving functionality was highly 
prioritised.
Prioritisation was not a static process and was subject 
to change, based on factors such as illness exacerbations, 
life events, whether there was a need for a treatment 
decision to be made, and whether the priority related to 
retrospective or prospective healthcare.49 51 When consid-
ering the hypothetical impact of an illness, perceptions 
of future risk came into play, and in particular, the risk 
of mortality.43 This was particularly evident in relation 
to cardiovascular disease, where patients appeared to 
perceive the risk of mortality to be high.38
Risk of mortality was a dominant driver for prioritisa-
tion among clinicians. This was shown in our quantitative 
synthesis, where among studies assessing disease- specific 
priorities, conditions with a higher risk of mortality, such as 
cardiovascular disease and diabetes, recurrently emerged 
as being highly prioritised by clinicians36 44 56 and differ-
entiated by age.47 This age- based consideration could 
explain why clinicians prioritised ‘quality of life for the 
patient’ as higher, although marginally, than ‘life expec-
tancy of the patient’ in their clinical decision- making for 
deprescribing for elderly, patients with multimorbidity.57
Smith et al previously developed a ‘Core Outcome Set’67 
in which a Delphi consensus panel formed of 26 inter-
national health experts, identified and prioritised a set 
of outcomes tailored for application to research studies 
targeting patients with multimorbidity. Mortality, mental 
health outcomes and quality of life featured most highly 
in their list of prioritised outcomes, which also emerged 
in this review. However, we found that relatively few studies 
reported the prioritisation of mental health outcomes, with 
the exception of the studies that took a problem- based 
approach to prioritisation, where problems with regard 
to ‘Mood’ were prioritised highly by both patients and 
clinicians.52–54
Our findings show a varying degree of agreement 
between the priorities of patients with multimorbidity and 
clinicians. Previous studies carried out in the context of 
diabetes,68 and psoriasis69 have found a low level of agree-
ment on health outcome and treatment priorities between 
patients and clinicians, which correlates with the findings of 
some studies included in this review,52–54 but not others.44 
The nature of the patients’ illnesses emerged as a factor 
for concordance or discordance of priorities with their 
clinicians.37 Patients and clinicians were in agreement in 
situations where patients were currently experiencing an 
exacerbation of a particular condition, or had a ‘stable’ 
state of health. However, in patients who suffered from 
illnesses with more complex courses, discordance of priori-
ties tended to occur between patients and clinicians.37
In recent times, the traditional paternalistic model for the 
doctor–patient relationship has given way to an egalitarian 
model,70 where doctors and patients each play an equitable 
role in a shared decision- making process, which places 
the patient at its core and thus achieving greater patient- 
centred care.70 71 A shared agreement between patients and 
doctors on treatment priorities have been highlighted to 
play an important part in achieving patient- centred care 
and creating a therapeutic alliance, the benefits of which 
can include improved treatment adherence.70 71 Indeed, 
Jowsey et al found that agreement between patients and 
clinicians in the formulation of care plans promoted adher-
ence to these plans, whereas a lack of agreement led to 
disengagement with care plans by patients.72
Strengths and limitations
To our knowledge, this is the first systematic review to 
assimilate and compare the findings of existing litera-
ture on the health outcome and treatment priorities of 
both patients and clinicians for patients living with multi-
morbidities. In this review, we have been able to add a 
novel line of argument to the ongoing discussion on this 
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subject. By incorporating papers using both qualitative 
and quantitative methodologies, we have been able to 
explore patterns and relationships in the findings of a 
wide range of studies, thus creating a comprehensive and 
well- rounded systematic review.
There are noteworthy limitations. We did not include 
the term ‘comorbidity’, in our search terms, and while 
‘comorbidity’ is distinctive from multimorbidity, there is 
also some conceptual overlap between the two terms. We 
felt that including ‘comorbidity’ in our search strategy 
would identify studies focusing on a specific condition 
rather than multimorbidity.
A number of the quantitative studies did not use preval-
idated tools to ascertain priorities,36 54 56–58 leading to a 
risk of measurement bias, which could limit the gener-
alisability of findings in this review. All of the included 
studies were conducted in developed, western countries, 
which limits the global generalisability of our findings, as 
the priorities of patients with multimorbidity and of clini-
cians in developing and/or eastern countries may differ 
to the findings of this review.
We also detected a large variation in the tools used 
to ascertain priorities, which meant that carrying out a 
meta- analysis to synthesise the findings of the quantitative 
studies was not possible. Yet, we have tried to mitigate the 
lack of meta- analysis by using a well- described and well- 
established method of narrative synthesis,33 in order to 
maintain rigour and transparency.
Another limitation is that, in our inclusion criteria, 
we chose to also include studies which did not explicitly 
specify a definition of multimorbidity as ‘two or more 
chronic conditions’ in their inclusion criteria but had a 
sample of participants that were reflective of multimor-
bidity (ie, with a minimum of two chronic conditions 
which could be identified from participant demographic 
data). We chose to do this as in the absence of a univer-
sally accepted and uniform definition of multimorbidity, 
we sought to base our judgement on the inclusivity of each 
paper on its value in answering our review question. This, 
along with the previously discussed difficulty in defining 
prioritisation, may have introduced a degree of subjective 
interpretation in the process of study selection, despite 
our attempt to mitigate this by incorporating indepen-
dent review of the results of our literature searching by 
two reviewers in duplicate.
recommendations for the future
We recommend that future guidelines developed for clini-
cians in the management of multimorbidity highlight the 
need to elicit and consider both short- term and long- term 
priorities for their patients’, as our review has shown that 
patients’ priorities for their current illness experiences 
and future risks posed by illnesses, may differ. In accor-
dance with current National Institute for Health and Care 
Excellence guidance, we also reiterate the need to review 
these priorities continually, and particularly when exacer-
bations, changes to illness course or treatment regimens, 
or other wider socially contextualised changes occur in 
their patients’ lives.
There was a large variation in how priorities were ascer-
tained, and in the tools used to ascertain priorities. The 
relative lack of standardised and validated tools for use 
to ascertain patient priorities in everyday clinical prac-
tice has also been described in previous literature.73 We 
highlight a need for the development of a standardised 
and validated tool that is acceptable to both patients and 
clinicians, and can be used to ascertain patient priorities 
in the multiple dimensions described in this review. Such 
a tool would a valuable aid to treatment decision making, 
advance care planning and achieving patient- centredness 
for patients living with multimorbidity.
COnCluSIOn
The findings from this review show the priorities of 
patients and clinicians can have varying degrees of concor-
dance, being mostly low,52 54 in alignment with previous 
findings in single disease contexts.68 69 We have found that 
the mechanisms of prioritisation can also differ between 
our two groups, in that patients are driven by illness expe-
riences, whereas clinicians may be focused on managing 
longer term risks. Understanding these differences can 
help clinicians to better recognise situations where the 
patients’ priorities may be different to theirs and elicit the 
most important priorities for their patients.
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